Literature DB >> 24432915

Obstructive sleep apnea syndrome and chronic kidney disease: a new cardiorenal risk factor.

Abdullah Ozkok1, Asiye Kanbay, Ali Riza Odabas, Adrian Covic, Mehmet Kanbay.   

Abstract

Clinical and experimental studies revealed that sleep apnea might be an insidious risk factor for the progression of kidney disease and development of cardiovascular events by exacerbating well-known risk factors, namely hypertension, type 2 diabetes mellitus and obesity. Furthermore, sleep apnea also has a negative impact on endothelial function. Therefore, sleep apnea might be defined as a new cardiorenal risk factor. In this review, we aimed to summarize the evidences supporting the complex inter-relations between sleep apnea and development and progression of chronic kidney disease.

Entities:  

Keywords:  Chronic kidney disease; hypertension; inflammation; sleep apnea

Mesh：

Substances：

Year:  2014        PMID： 24432915     DOI： 10.3109/10641963.2013.804546

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN： 1064-1963            Impact factor:   1.749


  10 in total

1.  Renoprotective effects of continuous positive airway pressure in chronic kidney disease patients with sleep apnea.

Authors:  Robert Puckrin; Sameena Iqbal; Arnold Zidulka; Murray Vasilevsky; Paul Barre
Journal:  Int Urol Nephrol       Date:  2015-09-30       Impact factor: 2.370

Review 2.  The Triad of Sleep Apnea, Hypertension, and Chronic Kidney Disease: A Spectrum of Common Pathology.

Authors:  Fahad Aziz; Kunal Chaudhary
Journal:  Cardiorenal Med       Date:  2016-11-05       Impact factor: 2.041

Review 3.  Potential Use of SGLT-2 Inhibitors in Obstructive Sleep Apnea: A new treatment on the horizon.

Authors:  Cem Tanriover; Duygu Ucku; Merve Akyol; Enes Cevik; Asiye Kanbay; Vikas S Sridhar; David Z I Cherney; Mehmet Kanbay
Journal:  Sleep Breath       Date:  2022-04-04       Impact factor: 2.816

Review 4.  Chronic Kidney Disease and Sleeping Disordered Breathing (SDB).

Authors:  Roberto Sávio Silva Santos; Shveta S Motwani; Rosilene Motta Elias
Journal:  Curr Hypertens Rev       Date:  2016

5.  Intermittent hypoxia exacerbates increased blood pressure in rats with chronic kidney disease.

Authors:  Jennifer L Riggs; Carolyn E Pace; Heather H Ward; Laura V Gonzalez Bosc; Lynnette Rios; Adelaeda Barrera; Nancy L Kanagy
Journal:  Am J Physiol Renal Physiol       Date:  2018-06-13

6.  Angiotensin-(1-7) relieved renal injury induced by chronic intermittent hypoxia in rats by reducing inflammation, oxidative stress and fibrosis.

Authors:  W Lu; J Kang; K Hu; S Tang; X Zhou; S Yu; L Xu
Journal:  Braz J Med Biol Res       Date:  2017-01-09       Impact factor: 2.590

7.  Sleep duration and chronic kidney disease: The Korean Genome and Epidemiology Study (KoGES)-Kangwha study.

Authors:  Hansol Choi; Hyeon Chang Kim; Joo Young Lee; Ju-Mi Lee; Dong Phil Choi; Il Suh
Journal:  Korean J Intern Med       Date:  2017-02-15       Impact factor: 2.884

8.  Obstructive sleep apnea is associated with impaired renal function in patients with diabetic kidney disease.

Authors:  Ester Zamarrón; Ana Jaureguizar; Aldara García-Sánchez; Trinidad Díaz-Cambriles; Alberto Alonso-Fernández; Vanesa Lores; Olga Mediano; Paula Rodríguez-Rodríguez; Sheila Cabello-Pelegrín; Enrique Morales-Ruíz; María T Ramírez-Prieto; María Isabel Valiente-Díaz; Teresa Gómez-García; Francisco García-Río
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

9.  Does obstructive sleep apnoea contribute to obesity, hypertension and kidney dysfunction in children? A systematic review protocol.

Authors:  Sara Rodriguez-Lopez; Stefan Palkowski; Christopher Gerdung; Diana Keto-Lambert; Meghan Sebastianski; Maria Luisa Castro-Codesal
Journal:  BMJ Open       Date:  2020-08-30       Impact factor: 2.692

10.  Self-reported snoring is associated with chronic kidney disease independent of metabolic syndrome in middle-aged and elderly Chinese.

Authors:  Jun Song; Chuan Wang; Aixia Ma; Huizhen Zheng; Wenjian Zheng; Xinguo Hou; Cheng Hu; Li Chen; Weiping Jia
Journal:  J Diabetes Investig       Date:  2018-06-05       Impact factor: 4.232
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.